PrimeGen Biotech Corporation and Unidym, Inc. Form Alliance to Optimize Development of Induced Pluripotent Stem Cells
IRVINE, Calif. & MENLO PARK, Calif.--(BUSINESS WIRE)--PrimeGen Biotech LLC and Unidym Inc., a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR), today announced a corporate alliance focused on exploring new applications for carbon nanotubes in stem cell medicine. Unidym brings to this partnership its leadership in carbon nanotube science, technology and production.